Dave Suchon
Dave Suchon is the co-founder, CEO, and director of Vimy Pharmaceuticals Inc., a company aimed at producing a made-in-Canada generic version of the diabetes drug Ozempic. With a background in law and biochemistry, he previously served as vice-president of corporate affairs at Novo Nordisk Canada, where he gained valuable experience in the pharmaceutical industry.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| Canada | 1 | 7.00 | 0.84% | +0% | 38,005,238 | 319,372 | $1,700,000 | 14,286$ |
| Totals | 1 | 38,005,238 | 319,372 | $1,700,000 | 14,286$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Canada:
Dave Suchon is the chief executive officer and co-founder of Vimy Pharma.
7
Canada:
Dave Suchon, the chief executive officer of Vimy Pharma, aims to create a Canadian-made and Canadian-owned producer of generic semaglutide.
8
Canada:
Dave Suchon is the co-founder, CEO, and director of Vimy Pharma, aiming to produce a made-in-Canada version of Ozempic.
8